Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Quetiapine (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 12 May 2009 Planned end date changed from 1 Jun 2008 to 1 Jan 2010 as reported by ClinicalTrials.gov.
- 15 Jan 2008 Status changed from initiated to recruiting.
- 25 Nov 2005 New trial record.